Condition

Bipolar Affective Disorder

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 16 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials16

Recruiting6

Common interventions19

Lead sponsors shown15

Clinical trials

16 shown

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.NCT07412132 · 2026-01-09

EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECTNCT07740694 · 2025-12-01

Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective DisorderNCT07858565 · 2025-10-30

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind ProjectNCT06743711 · 2025-01-01

Medical Phenotyping of NHS General Adult Psychiatry (GAP) InpatientsNCT07398365 · 2024-04-03

Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI AgentsNCT06904079 · 2024-03-12

Treatment Response In ECT PatientsNCT07463911 · 2025-05-20

ACTIVE_NOT_RECRUITING

DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in PsychosisNCT06978465 · 2025-05-19

NOT_YET_RECRUITING

A Study on the Preference of Risperidone Dosage FormsNCT06657430 · 2024-09-19

Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With CatatoniaNCT06176456 · 2023-11-01

Exosome for Early Diagnosis of Bipolar Affective DisorderNCT05915312 · 2023-06-15

Somatic Comorbidities in Psychiatric PatientsNCT02773108 · 2016-05-01

The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled TrialNCT02453217 · 2016-03-31

Improving Work Outcome for People With Severe Mental IllnessNCT01722344 · 2012-10-01

Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With SchizophreniaNCT01431092 · 2011-10-01

Specialized Clozapine Clinic for Bipolar and Schizoaffective DisorderNCT00683709 · 2007-01-01

Common interventions

PlaceboDRUG2 CBTBEHAVIORAL1 Chinese CHIPBEHAVIORAL1 Counselling as UsualBEHAVIORAL1 Electroconvulsive TherapyDEVICE1 Electroconvulsive Therapy (ECT)DEVICE1 Gamified Digital RehabilitationOTHER1 Individual Placement and support (IPS)BEHAVIORAL1 IPS plusBEHAVIORAL1 LacosamideDRUG1 MelatoninDRUG1 PlaceboOTHER1 Questionnaires, rating scales, & review of notesOTHER1 Quetiapine (drug)DRUG1 quetiapine + aripiprazoleDRUG1 quetiapine + haloperidolDRUG1 Routine CareBEHAVIORAL1 rTMSDIAGNOSTIC_TEST1 Treatment as usualOTHER1

Leading sponsors

Shanghai Mental Health Center 2 Bjorn H. Ebdrup 1 Bosnalijek D.D 1 Douglas Mental Health University Institute 1 Istanbul University - Cerrahpasa 1 Lone Baandrup 1 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 1 Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev 1 Nurdan Sağbaş 1 St. Joseph's Healthcare Hamilton 1 Sveti Ivan Psychiatric Hospital 1 Tianjin Anding Hospital 1 University of Edinburgh 1 University of Sao Paulo 1 Wai-Tong Chien 1

Trial status mix

RECRUITING6

COMPLETED5

UNKNOWN3

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

Phase mix

NA4

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.